Pharmacogenomics is one of the key aspects of personalized medicine, focusing on how an individual’s DNA affects the way they respond to medications. All individuals have different genetic make-up so they respond differently to the same medication. Pharmacogenomics allows customized treatment for a wide range of health problems including; cardiovascular disease, Alzheimer’s disease, cancer, HIV/AIDS, and asthma.
Often, drug choice and dosage require experimentation in order to find the best treatment option. With pharmacogenomics testing, the need for this experimentation is decreased. As a result, the process becomes faster and more cost-effective and the possibility of adverse events caused by the wrong drug choice or dosage is significantly reduced.
Pharmacogenomics has increasingly become an area of interest to clinicians because of the potential to tailor pharmacotherapy based on genetic variations in patients. One avenue for implementing pharmacogenomics is through medication therapy management (MTM), where pharmacists assess and evaluate a patient’s complete medication therapy regimen. By gathering key pieces of information, e.g. which medications and supplements a patient is currently taking, pharmacists can assess current treatment and suggest alternative therapies.
Access Market Intelligence’s new report, Pharmacogenomics Providers, identifies the leading providers of pharmacogenomics testing, and provides contact information, company background, tests, and recent activities. The Table of Contents includes:
Pharmacogenomics Background – pgs. 4-5
Pharmacogenomics Providers – pgs. 6-47
- 23andMe – pgs. 6-13
- Aderma Health – pgs. 14 -16
- Alpha Genomix – pgs. 17-20
- Color Genomics – pgs. 21-22
- Dynamic DNA Laboratories – pg. 23
- GeneDx – pgs. 24-27
- Genelex – pgs. 28-29
- Genomind – pgs. 30-31
- Kailos Genetics – pgs. 32-33
- Myriad Neuroscience/GeneSight – pgs. 34-35
- OneOme – pgs. 36-37
- Pathway Genomics – pgs. 38-39
- PGx Medical – pgs. 40-41
- RM Genetics – pg. 42
- RxGenomix – pg. 43
- Rxight/MD Labs – pg. 44
- Veritas Genetics – pgs. 45-47
References and Sources – pg. 48